Evidence map›Paper›PMID 39877668›Full record

ReviewJACC. Advances2025

Naxos Disease and Related Cardio-Cutaneous Syndromes.

Alexandros Protonotarios, Angeliki Asimaki, Cristina Basso, Zafeirenia Xylouri, Emanuele Monda, Ioannis Protonotarios, Giulia Crisci, Dominic Jr Abrahms, Aris Anastasakis, Loizos Antoniades and 21 more

Abstract readReview
In one paragraph

Review in JACC. Advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors.

Alexandros ProtonotariosCentre for Heart Muscle Disease, UCL Institute of Cardiovascular Science, London, UK.
Angeliki AsimakiCardiovascular and Genomics Research Institute of City, St George's University of London, London, UK.
Cristina BassoUniversity of Padua, Medical School, Padua, Italy.
Zafeirenia XylouriAcute Medicine, Southampton General Hospital, Southampton, UK.
Emanuele MondaDepartment of Traslational Sciences, University of Campania 'Luigi Vanvitelli', Naples, Italy.
Ioannis ProtonotariosCardiovascular and Genomics Research Institute of City, St George's University of London, London, UK.
Giulia CrisciUniversity of Naples Federico II, Naples, Italy; Department of Cardiology, San Paolo Hospital, University of Milan, Milan, Italy.
Dominic Jr AbrahmsCenter for Cardiovascular Genetics, Boston Children's Hospital, Harvard Medical School, Boston, USA.
Aris AnastasakisInherited Cardiovascular Diseases, Onassis Cardiac Surgery Centre, Athens, Greece.
Loizos AntoniadesUniversity of Cyprus Medical School, Nicosia, Cyprus.
Athanasios BakalakosCentre for Heart Muscle Disease, UCL Institute of Cardiovascular Science, London, UK.
Andreina CarboneUniversity of Naples Federico II, Naples, Italy.
Aman S CoonarCardiothoracic Surgery, Royal Papworth Hospital, Cambridge University Health Partners, Cambridge, UK.
Juan Ramon GimenoInherited Cardiac Disease Department (CSUR/ ERN Guard Heart), Virgen de la Arrixaca University Hospital, Murcia, Spain.
George LazarosGeorge Lazaros, First Cardiology Department, School of Medicine, Hippokration General Hospital, National and Kapodistrian University of Athens, Athens, Greece.
Stamatios LerakisDepartment of Cardiology, Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai, New York, NY.
Luisa MestroniMedicine/Cardiology, Genetics Program, University of Colorado Cardiovascular Institute, Aurora, USA.
George PapadopoulosUniversity of Athens Medical School, Athens, Greece.
Leandro PecchiaUniversity Campus Biomedico, Rome, Italy.
Francesca Romana PrandiWeill Cornell, NY Presbyterian Hospital, New York, USA.
Petros SyrrisCentre for Heart Muscle Disease, UCL Institute of Cardiovascular Science, London, UK.
Julia Cadrin-TurignyCardiovascular Genetics Center, Montréal Heart Institute, Faculty of Medicine, University of Montréal, Montréal, Québec, Canada.
Anargyros VasilakisRepresentative of Naxos disease patients, Naxos, Cyclades, Greece.
Jeffrey E SaffitzHarvard Medical School, Department of Pathology, Beth Israel Deaconess Medical Center, Boston, USA.
Gaetano ThieneUniversity of Padua, Medical School, Padua, Italy.
Perry M ElliottCentre for Heart Muscle Disease, UCL Institute of Cardiovascular Science, London, UK.
Juan Pablo KaskiCentre for Heart Muscle Disease, UCL Institute of Cardiovascular Science, London, UK.
William J McKennaCentre for Heart Muscle Disease, UCL Institute of Cardiovascular Science, London, UK.
Eduardo BossoneUniversity of Naples Federico II, Naples, Italy.
Giuseppe LimongelliDepartment of Traslational Sciences, University of Campania 'Luigi Vanvitelli', Naples, Italy.
Adalena TsatsopoulouPrecision Medicine Network in Cardiology Onassis Cardiac Surgery Center, Athens, Greece; Pediatric Clinic, Naxos, Cyclades, Greece. Electronic address: adalenatsatsop@gmail.com.

Funding

British Heart Foundation PG/23/11166Medical Research Council MR/T024062/1
6 · The paper itself

Abstract

Naxos disease is a rare autosomal recessive condition combining arrhythmogenic right ventricular cardiomyopathy, woolly hair, and palmoplantar keratoderma. The first identified causative variant was in the gene encoding the desmosomal protein plakoglobin. Naxos disease exhibits fibro-fatty myocardial replacement with immunohistological abnormalities in cardiac protein and signaling pathways, highlighting the role of inflammation and potential anti-inflammatory treatments. Childhood cutaneous signs precede cardiac features, which are diagnosed by familial and genetic evaluation, electrocardiography and cardiac imaging. Disease progression necessitates holistic care with risk management and lifestyle adjustments, often needing treatment for arrhythmia and heart failure. Similar phenotypes have been linked to desmoplakin and rarely desmocollin2 gene variants, highlighting the importance of familial and genetic evaluation. This document summarizes current knowledge on Naxos disease and related cardiocutaneous syndromes and initiates an international endeavor to collect and study all global cases, aiming to improve understanding, treatment, and patient care through shared data and research.

Indexed as

arrhythmogenic cardiomyopathiesarrhythmogenic right ventricular cardiomyopathycardio-cutaneous syndromedesmoplakinNaxos diseaseplakoglobin

Identifiers

PMID39877668
PMCPMC11773020

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.